|
Volumn 67, Issue 4, 2001, Pages 165-169
|
Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
HEPARIN;
HEPARIN ANTAGONIST;
PROTAMINE;
ARTICLE;
BLOOD;
BLOOD CLOTTING;
BLOOD CLOTTING TIME;
CARDIOPULMONARY BYPASS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
HEMOSTASIS;
HUMAN;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SENSITIVITY AND SPECIFICITY;
ANTICOAGULANTS;
BLOOD COAGULATION;
CARDIOPULMONARY BYPASS;
FEMALE;
HEMOSTASIS, SURGICAL;
HEPARIN;
HEPARIN ANTAGONISTS;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
PROTAMINES;
SENSITIVITY AND SPECIFICITY;
WHOLE BLOOD COAGULATION TIME;
|
EID: 0035317890
PISSN: 03759393
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|